Short-course High-dose Prednisone and Dexamethasone in Children With ITP
Recruiting
Phase 4
Interventional Study
Immune Thrombocytopenia
Glucocorticoids
Child, Only
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 29 Days – 14
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 608 (estimated)
- Sponsor
- Fujian Medical University Union Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Comparison of the efficacy and safety of short-course high-dose prednisone and dexamethasone in the treatment of children with newly diagnosed immune thrombocytopenia (ITP)
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:Subjects enrolled in this study must meet all of the following criteria:
1. Meet the ITP diagnostic criteria, within 3 months of the first diagnosis
2. Age \> 28 days and ≤ 14 years old
3. Untreated PLT\<20×109/L, or PLT\<30×109/L after 1 week of intravenous gamma globulin (IVIG)…
Contacts